Philip Seeman's contributions to the story of schizophrenia
Philip Seeman's isolation of the dopamine D2 receptor is an example of a small step that can lead to major change in the way that we conceptualize the etiology of schizophrenia.
Gespeichert in:
| Veröffentlicht in: | Psychological medicine 2022-10, Vol.52 (13), p.2401-2403 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2403 |
|---|---|
| container_issue | 13 |
| container_start_page | 2401 |
| container_title | Psychological medicine |
| container_volume | 52 |
| creator | Seeman, Mary V. |
| description | Philip Seeman's isolation of the dopamine D2 receptor is an example of a small step that can lead to major change in the way that we conceptualize the etiology of schizophrenia. |
| doi_str_mv | 10.1017/S0033291721004803 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9647513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291721004803</cupid><sourcerecordid>2734091501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-94bc29b6c548eda39132908ff684519e5e18e086f498dfe7a33148015c1ed0363</originalsourceid><addsrcrecordid>eNp1kE1LxDAURYMoOI7-AHcFF66qeU3aJgiCiF8woDC6Dmn6Os0wbWrSCuOvt8MMioirLG7ueYdLyCnQC6CQX84pZSyRkCdAKReU7ZEJ8EzGQuZin0w2cbzJD8lRCEtKgQFPJuTqpbYr20VzxEa35yEyru29LYbeujZEvYv6GqPQO7-OXBUFU9tP19UeW6uPyUGlVwFPdu-UvN3fvd4-xrPnh6fbm1lsOKR9LHlhEllkJuUCS80kjKJUVFUmeAoSUwSBVGQVl6KsMNdsVBMUUgNYUpaxKbnecruhaLA0OBrqleq8bbRfK6et-p20tlYL96FkxvMU2Ag42wG8ex8w9GrpBt-OzirJGacS0nGPKYHtL-NdCB6r7wtA1WZk9WfkscN2Hd0U3pYL_EH_3_oCzCl-LA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2734091501</pqid></control><display><type>article</type><title>Philip Seeman's contributions to the story of schizophrenia</title><source>Cambridge Journals</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>Seeman, Mary V.</creator><creatorcontrib>Seeman, Mary V.</creatorcontrib><description>Philip Seeman's isolation of the dopamine D2 receptor is an example of a small step that can lead to major change in the way that we conceptualize the etiology of schizophrenia.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291721004803</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Antipsychotics ; Dopamine ; Dopamine D2 receptors ; Drug dosages ; Etiology ; Membranes ; Mental disorders ; Parkinson's disease ; Personal Tribute ; Pharmacology ; Plasma ; Psychosis ; Psychotropic drugs ; Schizophrenia</subject><ispartof>Psychological medicine, 2022-10, Vol.52 (13), p.2401-2403</ispartof><rights>Copyright © The Author(s), 2022. Published by Cambridge University Press</rights><rights>Copyright © The Author(s), 2022. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-94bc29b6c548eda39132908ff684519e5e18e086f498dfe7a33148015c1ed0363</citedby><cites>FETCH-LOGICAL-c415t-94bc29b6c548eda39132908ff684519e5e18e086f498dfe7a33148015c1ed0363</cites><orcidid>0000-0001-6797-3382</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0033291721004803/type/journal_article$$EHTML$$P50$$Gcambridge$$Hfree_for_read</linktohtml><link.rule.ids>164,230,314,780,784,885,12846,27924,27925,30999,55628</link.rule.ids></links><search><creatorcontrib>Seeman, Mary V.</creatorcontrib><title>Philip Seeman's contributions to the story of schizophrenia</title><title>Psychological medicine</title><addtitle>Psychol. Med</addtitle><description>Philip Seeman's isolation of the dopamine D2 receptor is an example of a small step that can lead to major change in the way that we conceptualize the etiology of schizophrenia.</description><subject>Antipsychotics</subject><subject>Dopamine</subject><subject>Dopamine D2 receptors</subject><subject>Drug dosages</subject><subject>Etiology</subject><subject>Membranes</subject><subject>Mental disorders</subject><subject>Parkinson's disease</subject><subject>Personal Tribute</subject><subject>Pharmacology</subject><subject>Plasma</subject><subject>Psychosis</subject><subject>Psychotropic drugs</subject><subject>Schizophrenia</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>IKXGN</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kE1LxDAURYMoOI7-AHcFF66qeU3aJgiCiF8woDC6Dmn6Os0wbWrSCuOvt8MMioirLG7ueYdLyCnQC6CQX84pZSyRkCdAKReU7ZEJ8EzGQuZin0w2cbzJD8lRCEtKgQFPJuTqpbYr20VzxEa35yEyru29LYbeujZEvYv6GqPQO7-OXBUFU9tP19UeW6uPyUGlVwFPdu-UvN3fvd4-xrPnh6fbm1lsOKR9LHlhEllkJuUCS80kjKJUVFUmeAoSUwSBVGQVl6KsMNdsVBMUUgNYUpaxKbnecruhaLA0OBrqleq8bbRfK6et-p20tlYL96FkxvMU2Ag42wG8ex8w9GrpBt-OzirJGacS0nGPKYHtL-NdCB6r7wtA1WZk9WfkscN2Hd0U3pYL_EH_3_oCzCl-LA</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Seeman, Mary V.</creator><general>Cambridge University Press</general><scope>IKXGN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6797-3382</orcidid></search><sort><creationdate>20221001</creationdate><title>Philip Seeman's contributions to the story of schizophrenia</title><author>Seeman, Mary V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-94bc29b6c548eda39132908ff684519e5e18e086f498dfe7a33148015c1ed0363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antipsychotics</topic><topic>Dopamine</topic><topic>Dopamine D2 receptors</topic><topic>Drug dosages</topic><topic>Etiology</topic><topic>Membranes</topic><topic>Mental disorders</topic><topic>Parkinson's disease</topic><topic>Personal Tribute</topic><topic>Pharmacology</topic><topic>Plasma</topic><topic>Psychosis</topic><topic>Psychotropic drugs</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seeman, Mary V.</creatorcontrib><collection>Cambridge Journals Open Access</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seeman, Mary V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Philip Seeman's contributions to the story of schizophrenia</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol. Med</addtitle><date>2022-10-01</date><risdate>2022</risdate><volume>52</volume><issue>13</issue><spage>2401</spage><epage>2403</epage><pages>2401-2403</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><abstract>Philip Seeman's isolation of the dopamine D2 receptor is an example of a small step that can lead to major change in the way that we conceptualize the etiology of schizophrenia.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><doi>10.1017/S0033291721004803</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-6797-3382</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0033-2917 |
| ispartof | Psychological medicine, 2022-10, Vol.52 (13), p.2401-2403 |
| issn | 0033-2917 1469-8978 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9647513 |
| source | Cambridge Journals; Applied Social Sciences Index & Abstracts (ASSIA) |
| subjects | Antipsychotics Dopamine Dopamine D2 receptors Drug dosages Etiology Membranes Mental disorders Parkinson's disease Personal Tribute Pharmacology Plasma Psychosis Psychotropic drugs Schizophrenia |
| title | Philip Seeman's contributions to the story of schizophrenia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A55%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Philip%20Seeman's%20contributions%20to%20the%20story%20of%20schizophrenia&rft.jtitle=Psychological%20medicine&rft.au=Seeman,%20Mary%20V.&rft.date=2022-10-01&rft.volume=52&rft.issue=13&rft.spage=2401&rft.epage=2403&rft.pages=2401-2403&rft.issn=0033-2917&rft.eissn=1469-8978&rft_id=info:doi/10.1017/S0033291721004803&rft_dat=%3Cproquest_pubme%3E2734091501%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2734091501&rft_id=info:pmid/&rft_cupid=10_1017_S0033291721004803&rfr_iscdi=true |